MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment collaborators. Plus, the keys making it through a down cycle like the industry has been in over recent years.

He describes his career path, including time in the lab and doing quant work at Goldman Sachs. Plus, what he has learned about VC investing and biotech over time, and how Omega Funds is able to successfully invest in various stages and rounds of companies.

He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.

Sara Nayeem describes her career path and how different firms she has worked for have had different approaches to investing. She introduces us to Enavate Sciences, and shares her thoughts on investing in various areas such as rare diseases and digital health.

D.A. Wallach describes how he went from music to healthcare/biotech investing, and the similarities he sees between the two industries. Plus, the firm's investment philosophy and how he partnered with Tim Wright to create the firm.

Beth Seidenberg tells the story of how her career went from physician, to product development in industry, to investor. She describes the qualities she looks for in an entrepreneur, and discusses the Los Angeles core of Westlake BioPartners.

Bryan Roberts discusses Venrock's history, moving from NYC to the Bay Area, his investment philosophy, portfolio construction and concentration, the types of entrepreneurs he looks for, what qualities make for a good early stage investor, thoughts on AI, Tech Bio, and more.